HPLC Method Validated for the Simultaneous Analysis of Cichoric Acid and Alkamides in Echinacea purpurea Plants and Products

Journal of Agricultural and Food Chemistry

Volumn 51, Issue 24, 2003, Pages 6922-6933

  Mølgaard, Per ^a,b   Johnsen, Søren ^a,b   Christensen, Peter ^a,b   Cornett, Claus ^a,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Department of Medicinal Chemistry   (Denmark)

^c Department of Analytical and Pharmaceutical Chemistry ^*  (Denmark)

Author keywords

Alkamides; Alkyl; Amides; Asteraceae; Caffeoyltartaric acid; Cichoric acid; Echinacea purpurea; Herbal medicine; HPLC quantification; Validation

Indexed keywords

ALKAMIDE DERIVATIVE; AMIDE; CAFFEIC ACID DERIVATIVE; CICHORIC ACID; ECHINACEA PURPUREA EXTRACT; FLAVANONE DERIVATIVE; HERBACEOUS AGENT; NARINGENIN; PHENOL DERIVATIVE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); DENMARK; DRUG ISOLATION; DRUG QUALITY; DRUG STRUCTURE; ECHINACEA; ECHINACEA PURPUREA; EVALUATION; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHILICITY; LIPOPHILICITY; NONHUMAN; PLANT BREEDING; PLANT TISSUE; QUANTITATIVE ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SAMPLE; STANDARD; TECHNIQUE; VALIDATION PROCESS;

AMIDES; CAFFEIC ACIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DENMARK; ECHINACEA; PLANT EXTRACTS; PLANT PREPARATIONS; QUALITY CONTROL; SUCCINATES;

ASTERACEAE; ECHINACEA PURPUREA;

EID: 0242439522     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf026158f     Document Type: Article

References (51)

1. Foster, S. Herbal remedies: Echinacea, the cold and flue remedy. Altern. Compl. Ther. 1995, 254-257.
2. Scaglione, F.: Lund, B. Efficacy in the treatment of the common cold of a preparation containing an Echinacea extract. Int. J. Immunother. 1995. 11, 163-166.
3. Brinkeborn, R.; Shah, D.; Geissbühler, S.; Degenring, F. H. Echinaforce til behandling af akut forkøleise. Resultaterne af et placebo-kontrolleret dobbeltblindforsøg foretaget i Sverige. Phytomedicine 1999, 6, 1-4.
4. Melchart, D.; Linde, K.; Fischer, P.; Kaesmayr, J. Echinacea for Preventing and Treating the Common Cold; The Cochrane Library, Issue 1; Update Software: Oxford, 2002.
5. Schranner, I.; Würdinger, M.; Klumpp, N.; Lösch, U.; Okpanyi, S. N. Beeinflussung der aviären humoralen Immunreaktionen durch Influex und Echinacea angustifolia Extrakt. J. Vet. Med. B 1989, 36, 353-364.
6. Steinmüller, C.; Roesler, J.: Gröttrup, E.; Franke, G.; Wagner, H; Lohmann-Matthes, M. L. Polysaccharides isolated from plant cell cultures of Echinacea purpurea enhance the resistance of immunosuppressed mice against systemic infections with Candida albicans and Listeria monocytogenes. Int. J. Immunpharmacol. 1993, 15, 605-614.
7. Burger, R. A.; Torres, R. T.; Warren, R. P.; Caldwell, V. D.; Hughes, B. G. Echinacea-induced cytochine production by human macrophages. Int. J. Immunopharmacol. 1997, 19, 371-379.
8. Rehman, J.; Dillow, J. D.; Carter, S. M.; Chou, J.; Le, B.; Maisel, A. S. Increased production of antigen-specific immunoglobulins G and M following in vivo treatment with the medicinal plants Echinacea angustifolia and Hydrastis canadensis. Immunol. Lett. 1999, 68, 391-395.
9. Rininger, J. A.; Kickner, S.; Chigurupati, P.; McLean, A.; Franck, Z. Immunopharmacological activity of Echinacea preparations following simulated digestion on murine macrophages and human peripheral blood mononuclear cells. J. Leucocyte Biol. 2000, 68, 503-510.
10. Goel, V.; Chang, C.; Sima, J. V.; Barton, R.; Bauer, R.; Gahler, R.; Basu, T. K. Echinacea stimulates macrophage function in the lung and spleen of normal rats. J. Nutr. Biochem. 2002, 13, 487-492.
11. Hu, C.; Kitts, D. D. Studies on the Antioxidant Activity of Echinacea Root Extract. J. Agric. Food Chem. 2000, 48, 1466-1472.
12. Thygesen, L.; Thulin, J.; Mortensen, A.; Skibsted, L. H.; Molgaard, P. Antioxidant Activity of Echinacea purpurea. Phytomedicine 2004, in press.
13. Bonadeo, I.; Bottazzi, G.; Lavazza, M. Echinacin B. Active polysaccharide of the Echinacea. Riv. Ital. Essenze, Profumi Piante Off., Aromi, Saponi, Cosmet., Aerosol 1971, 53, 281-295.
14. Facino, R. M.; Carini, M.; Aldini, G.; Saibene, L.; Pietta, P.; Mauri, P. Echinacoside and Caffeoyl Conjugates Protect Collagen from Free Radical-Induced Degradation: A Potential Use of Echinacea Extracts in the Prevention of Skin Photodamage. Planta Med. 1995, 61, 510-514.
15. Parnham, M. J. Benefit-risk assessment of the squeezed sap of the purple coneflower (Echinacea purpurea) for long-term oral immunostimulation. Phytomedicine 1996, 3, 95-102.
16. Bauer, R.; Wagner, H. Echinacea. Handbuch für Ärzte, Apotheker und andere Naturwissenschaftler; Wissenschaftlische Verlagsgesellschaft mbH: Stuttgart, Germany, 1990.
17. Barrett, B. C.; Brown, R. L.; Locken, K.; Maberry, R.; Bobula, J. A.; D'Alessio, D. Treatment of the Common Cold with Unrefined Echinacea. Ann. Intern. Med. 2002, 137, 939-946.
18. Bauer, R.; Remiger, P.; Wagner, H. Echinacea. vergleichende DC- und HPLC-Analyse der Herba-Drogen von Echinacea purpurea, E. pallida und E. angustifolia). Dtsch. Apoth. Ztg. 1988, 128, 174-180.
19. Bauer, R.; Remiger, P. Der Einsatz der HPLC bei der Standardisierung von Echinacea-Drogen. Arch. Pharm. 1989, 322, 324.
20. Bauer, R.; Remiger, P.; TLC and HPLC Analysis of Alkamides in Echinacea Drugs. Planta Med. 1989, 55, 367-371.
21. Bauer, R.; Remiger, P.; Jurcic, K.; Wagner, H. Beeinflussung der Phagozytose-Aktivität durch Echinacea-Extrakte. Z. Phytother. 1989, 43-48.
22. Bauer, R.; Foster, S. Analysis of Alkamides and Caffeic Acid Derivatives from Echinacea simulata and E. paradoxa Roots. Planta Med. 1991, 57, 447-449.
23. Bauer, R.; Tittel, G. Quality assessment of herbal preparations as a precondition of pharmacological and clinical studies. Phytomedicine 1996, 2, 193-198.
24. Schieffer, G. W. Validated HPLC Method for Caffeic-Acid Derivatives and Alkylamides in Echinacea Solid-Dosage Forms Using a Single Extraction Procedure. Journal of the American Nutraceutical Association 2000, 3, 67-81.
25. Schieffer, G. W.; Michael, K. HPLC assay of Echinacea purpurea/ Goldenseal (Hydrastis canadensis) combination formulations for phenolic acids, alkylamides, and alkaloids. J. Liq. Chromatogr. Relat. Technol. 2002, 25, 263-274.
26. He, X. G.; Lin, L. Z.; Lian, M. W. B. L. Z. Analysis of alkamides in roots and achenes of Echinacea purpurea by liquid chromatography-electrospray mass spectroinetry. J. Chromatogr. A 1998, 815, 205-211.
27. Baum, B. R.; Mechanda, S.; Livesay, J. F.; Binns, S. E.; Arnason, J. T. Predicting quantative phytochemical markers in single Echinacea plants or clones from their DNA fingerprints. Phytochemistry 2001, 56, 543-549.
28. Binns, S. E.; Arnason, J. T.; Baum, B. R. Phytochemical variation within populations of Echinacea angustifolia DC. (Asteraceae). Biochem. Syst. Ecol. 2002, Model 1, 1-18.
29. Binns, S. E.; Livesey, J. F.; Amason, J. T.; Baum, B. R. Phytochemical Variation in Echinacea from Roots and Flowerheads of Wild and Cultivated Populations. J. Agric. Food Chem. 2002, 50, 3673-3687.
30. Nüsslein, B.; Kurzmann, M.; Bauer, R.; Kreis, W. Enzymatic Degradation of Cichoric Acid in Echinacea purpurea Preparations. J. Nat. Prod. 2000, 63, 1615-1618.
31. Tobler, M.; Schneider, E. Naturgerechte Standardisierung von Phytopharmaka. Z. Phytother. 2001, 22, 10-21.
32. Bergeron, C.; Gafner, S.; Batcha, L. L.; Angerhofer, C. K. Stabilization of Caffeic Acid Derivatives in Echinacea purpurea L. Glycerin Extract. J. Agric. Food Chem. 2002, 50, 3967-3970.
33. Glowniak, K.; Zgorka, G.; Kozyra, M. Solid-phase extraction and reversed-phase high-performance liquid chromatography of free phenolic acids in some Echinacea species. J. Chromatogr. A 1996, 730, 25-29.
34. Perry, N. B.; Burgess, E. J.; Glennie, V. 1. Echinacea Standardization: Analytical Methods for Phenolic Compounds and Typical Levels in Medicinal Species. J. Agric. Food Chem. 2001, 49, 1702-1706.
35. Perry, N. B.; Klink, J. W. v.; Burgess, E. J.; Parmenter., G. A. Alkamide Levels in Echinacea purpurea: A Rapid Analytical Method Revealing Differences among Roots, Rhizomes, Stems, Leaves and Flowers. Planta Med. 1997, 63, 58-62.
36. Perry, N. B.; Klink, J. W. v.; Burgess, E. J.; Parmenter, G. A. Alkamide levels in Echinacea purpurea: Effects of Processing, Drying and Storage. Planta Med. 2000, 66, 54-56.
37. Laasonen, M.; Wennberg, T.; Harmia-Pulkkinen, T.; Vuorela, H. Simultaneous Analysis of Alkamides and Caffeic Acid Derivatives for the Identification of Echinacea purpurea, Echinacea angustifolia, Echinacea pallida and Parthenium integrifolium Roots. Planta Med. 2002, 68, 572-574.
38. Gotti, R.; Pomponio, R.; Bertucci, C.; Cavrini, V. Simultaneous analysis of the lipophilic and hydrophilic markers of Echinacea plant extracts by capillary electrophoresis. J. Sep. Sci. 2002, 25.
39. Gocan, S.; Radu, L.; Hadaruga, M. Simultaneous Analysis by High Performance Liquid Chromatography of Hydrophilic Compounds and Lipophilic Compounds (Alkamides) from Pharmaceutical Preparations of Echinacea purpurea Root. Chromatographia 2003, 57, 677-679.
40. Luo, X.-B.; Chen, B.; Yao, S.-Z.; Zeng, J.-G. Simultaneous analysis of caffeic acid derivatives and alkamides in root and extracts of Echinacea purpurea by high-performance liquid chromatography-photodiode array detection-electrospray mass spectrometry. J. Chromatogr. A 2003, 986, 73-81.
41. Danish Food and Drug Administration. http://www.dkma.dk/laegemiddel/natur/naturlm.asp.
42. Hoheisel, O.; Sandberg, M.; Bertram, S.; Bulitta, M.; Schäfer, M. Echinagard treatment shortens the course of the common cold: a double-blind, placebo-controlled clinical trial. Eur. J. Clin. Res. 1997, 9, 261-268.
43. Blaschek, W.; Döll, M.; Franz, G. Echinacea-Polysaccharide. Z. Phytother. 1998, 19, 255-262.
44. Speroni, E.; Govoni, P.; Guizzardi, S.; Renzulli, C.; Guerra, M. C. Anti-inflammatory and cicatrizing activity of Echinacea pallida Nutt. root extract. J. Ethnopharmacol. 2002, 79, 265-272.
45. Hobbs, C. The Echinacea Handbook; Eclectic Medical Publications: Portland, OR, 1989.
46. Bauer, R. Chemistry, Analysis and Immunological Investigations of Echinacea Phytopharmaceuticals; Birkhäuser: Basel, Switzerland, 1999; Vol. 8.
47. Luettig, B.; Steinmüller, C.; Gifford, G. E.; Wagner, H.; Lohmann-Matthes, M.-L. Macrophagen Activation by the Polysaccharide Arabinogalactan Isolated from Plant Cell Cultures of Echinacea purpurea. J. Natl. Cancer Inst. 1989, 81, 669-675.
48. Samuelson, A. B.; Paulsen, B. S.; Wold, J. K.; Otsuka, H.; Yamada, H.; Espevik, T. Isolation and Partial Characterization of Biologically Active Polysaccharides from Plantago major L. Phytother. Res. 1995, 9, 211-218.
49. Anonymous. Purple Coneflower Root-Echinacea purpurea radix. Pharmeuropa 2002, 14, 140-142.
50. Bomme, U., Hölzl, J.; Hessler, C.; Stahn, T. Wie beinnflusst die Sorte Wirkstoffgehalt und Ertrag von Echinacea purpurea (L.) Moench im Hinblick auf die pharmaceutische Nutzung? Landwirtsch. Jahrb. 1992, 149-164.
51. Johnsen, S. Seasonal Variation in Cichoric Acids and Alkamide Content of Echinacea purpurea; Royal Danish School of Pharmacy: Copenhagen, Denmark, 2001.